baber/WOPTO huggingface dataset:
Patent EP-1504918-A4 (EP)
Title: Laminate for printing and, printing method and printed matter using the same
Inventor: YUKAWA SHIGEO
IPC: B41M7/00
Filed: 2003-05-12
Abstract: A laminate for printing for coloring a resin layer by allowing a sublimable dyeing agent to permeate into the inside of the resin layer through heating, which comprises, in the order from the surface, a surface resin layer A (1) having a weak affinity with the sublimable dyeing agent and allowing the dyeing agent to pass through it and a coloring resin layer B (12) having strong affinity with the dyeing agent and preventing the transfer of the dyeing agent; and a printing method and a printed matter using the laminate. The laminate for printing has, formed as an inner layer, a coloring resin layer having strong affinity with a sublimable dyeing agent and capable of preventing the transfer of the dyeing agent, which allows the prevention of the transfer of a sublimable dyeing agent having been printed. <IMAGE>
Patent EP-1557885-A4 (EP)
Inventor: KOBAYASHI HIROYA
IPC: H04N5/335
Filed: 2003-10-08
Abstract: この発明は、ＦＯＰとＣＣＤ読出部との接合時に静電破壊し難い構造を備えた撮像装置等に関する。当該撮像装置は、光入射面としての裏面と対向した前面上にＣＣＤ読出部が設けられた半導体基板と、半導体基板が固定されるキャビティを有するパッケージと、キャビティの上部開口を覆う蓋と、半導体基板に接合されるＦＯＰと、電気配線とを備える。蓋は、ＦＯＰをキャビティ内に挿入するための案内口を有し、半導体基板は、ＣＣＤ読出部が設けられた領域に対応する部分が薄型化されている。また、半導体基板は、ＣＣＤ読出部とキャビティ底面とが向き合うように該底面に固定される一方、ＦＯＰの出射端面は、案内口からキャビティに挿入された状態で、半導体基板の薄型化された部分に光学的に結合されている。
Patent EP-1551796-A4 (EP)
Inventor: KWON TAESOO
IPC: C07C253/16
Filed: 2003-09-30
Abstract: L'invention concerne une synthèse améliorée de synthéton ECHB commercialement importante débutant avec du 3-hydroxy-η-butyrolactone rapidement disponible. La réaction s'effectue au cours d'une procédure dans un pot unique sans isolation ou purification des intermédiaires. Elle présente l'avantage des procédures préalablement utilisées qui consiste à utiliser des réactifs et des conditions minimisant les effets secondaires non désirés et pouvant être utilisés rapidement à une échelle commerciale. Le produit est fabriqué en grande quantité et facilement purifié en vue de fournir un intermédiaire excellent pour une synthèse ultérieure de produits importants sur le plan commercial tels que de la L-carnitine et des substances actives importantes sur le plan pharmaceutique utilisées dans des produits inhibiteurs de réductase HMG-coA tels que du Lipitor®.
Patent EP-1581848-A4 (EP)
Inventor: BOTAS JUAN
IPC: G06F19/00
Filed: 2003-07-14
Abstract: L'invention concerne des outils permettant d'obtenir et d'analyser des données concernant les caractéristiques physiques ou comportementales d'une population de spécimens biologiques, pour l'identification, le traitement ou le regroupement d'informations sur l'état de la population de spécimens. Dans un aspect de l'invention, un système informatique est utilisé pour évaluer un état d'un spécimen biologique, le système permettant d'étudier les caractéristique physiques d'un échantillon comprenant plusieurs spécimens. L'état peut comprendre un état du système nerveux central humain. L'invention concerne également une interface-utilisateur formée d'un écran informatique, d'une partie d'interface d'entrée et d'un mécanisme de traitement. L'interface-utilisateur peut également être équipée d'un mécanisme d'entrée d'informations de spécimen. Le mécanisme d'entrée d'informations de spécimen peut comprendre une entrée de type de spécimen permettant à l'utilisateur de préciser, sur l'écran informatique, le type de spécimen à étudier.
Patent EP-1558177-A4 (EP)
Title: Endograft device to inhibit endoleak and migration
Inventor: ETON DARWIN
IPC: A61F/
Filed: 2003-10-20
Abstract: An implantable endograft device (10) that may be characterized as an endograft assembly that is effectively anchored with respect to the weakened blood vessel (24) by filling the aneurysmal sac 20 to preclude further enlargement thereof and to anchor (14) the endograft with respect to the aneurysm. In this way, migration of the endograft is inhibited and exposure of the aneurysmal sac to endoleak circulatory pressures is limited thereby minimizing the risk of vessel wall rupture.
Patent EP-1584215-A4 (EP)
Inventor: VELICAN ZELJKO
IPC: H04R3/04
Filed: 2004-01-13
Abstract: L'invention concerne un système de haut-parleur apte à être utilisé dans un espace confiné, qui comprend un transducteur électroacoustique et une enceinte destinée à ce dernier. Ladite enceinte combine une topologie de deuxième ordre afin de produire une réponse acoustique montante (40) pour le système à une vitesse de deuxième ordre et un résonateur de Helmholtz conçu pour modifier la vitesse de montée de la réponse par rapport à la vitesse de deuxième ordre de façon que la réponse soit atténuée par rapport à la vitesse de deuxième ordre mais soit accentuée par rapport à une réponse plate, dans une partie sensible d'une bande passante du système au moins à une ou à des fréquences sélectionnées. Ledit système présente un moyen situé dans un chemin électrique alimentant le transducteur électroacoustique qui permet d'égaliser la réponse montante afin d'obtenir une marge de sécurité dynamique étendue au moins à la ou aux fréquences sélectionnées.
Patent EP-1628969-A4 (EP)
Inventor: LIM HONG
IPC: C07D405/04
Filed: 2004-05-28
Abstract: L'invention concerne des dérivés de benzopyrane substitués par un dérivé de benzimidazole ou leurs sels acceptables sur le plan pharmaceutique, une méthode de préparation de ces dérivés et des compositions pharmaceutiques les contenant. Les dérivés de benzopyrane substitués par un dérivé de benzimidazole, représenté par la formule (1), remplissent une fonction de protection du coeur contre la reperfusion ischémique sans créer d'effets secondaires, tels que la vasodilatation, ce qui permet d'utiliser une composition pharmaceutique contenant des dérivés de benzopyrane substitués par un dérivé de benzimidazole ou leurs sels acceptables sur le plan pharmaceutique, en tant qu'ingrédients actifs afin de protéger des tissus soumis à une reperfusion ischémique, par exemple, afin de protéger le coeur, les cellules nerveuses, le cerveau, les cellules rétiniennes, les organes de stockage, ainsi que pour traiter des maladies provoquées par la reperfusion ischémique.
Patent EP-1775237-A4 (EP)
Title: A platform container for the transportation of cylinder-shaped cargo
Inventor: KONG HEQING
IPC: B65D19/00
Filed: 2005-01-13
Abstract: A platform container for carrying large columned cargos comprises two bottom side rails parallel to each other, a plurality of bottom cross members provided between the two bottom side rails, and two end sills disposed to the ends of the two bottom side rails. A recess is provided on the bottom surface of the joint part of the bottom cross member where the bottom cross member joins the bottom side rail, such that the platform container is adapted for being guided by the recess along the roll guide when the platform container is dragged from a trailer or train to another trailer through the roll guide.
Patent EP-1709404-A4 (EP)
Inventor: BRADSHAW JOHN THOMAS
IPC: G01N21/27
Filed: 2005-01-21
Abstract: L'invention concerne un appareil et un procédé associé d'étalonnage optique de spectrophotomètres. L'appareil est un support d'étalonnage comprenant au moins une cuvette remplie d'une solution d'intérêt. Les cuvettes sont scellées, de sorte à empêcher l'évaporation. Les cuvettes comportent également un composant compressible permettant l'expansion de la solution, ainsi qu'un mécanisme de régulation de bulles destiné à empêcher le composant compressible de se retrouver sur le trajet du faisceau. L'appareil selon l'invention peut comprendre facultativement un élément de verre à densité neutre servant à détecter les changements optiques survenant dans les solutions au fil du temps.
Patent EP-1763017-A4 (EP)
Title: Sound encoder and sound encoding method
Inventor: OSHIKIRI MASAHIRO
IPC: G10L19/00
Filed: 2005-07-14
Abstract: Even when a combination of the stegonography technique and prediction encoding is applied to sound encoding, a sound encoder does not cause deterioration in quality of decoded signals. In the device, an encoding section (102) outputs an encoding code (I) to a bit embedding section (104). A function extension encoding section (103) generates an encoding code (J) for information required for extending functions of the sound encoder (100) and outputs it to the bit embedding section (104). The bit embedding section (104) embeds information on the encoding code (J) into a part of bits of the encoding code (I) and outputs the resultant encoding code (I'). A synchronization information generating section (106) generates synchronization information according to the encoding code (I') after the bit embedding and outputs the synchronization information to the encoding section (102). The encoding section (102) updates the internal state and the like on the basis of the synchronization information and encodes the next digital sound signal (X).
Patent EP-1825028-A4 (EP)
Title: Electrolysis cell electrolyte pumping system
Inventor: HELMKE JOACHIM
IPC: C25B15/08
Filed: 2005-11-02
Abstract: A system for pumping electrolyte through an electrolysis cell where the pressure of at least a portion of the gas generated by the electrolysis cell is used as driving force for the pumping. The system may include an electrolyte reservoir and a pumping chamber connected via an inlet conduit to receive electrolyte from the electrolysis cell and connected via an outlet conduit to flow electrolyte to the electrolysis cell. The pumping chamber is connected to the electrolysis cell to receive at least a portion of the gas generated by the electrolysis cell to elevate the pressure of the electrolyte therein and force it into the electrolysis cell.
Patent EP-1954931-A4 (EP)
Inventor: EINOLA KALLE
IPC: F02B3/06
Filed: 2006-11-28
Abstract: Procédé de commande d'une source (1, 10) d'énergie de machine d'exploitation forestière, ladite source d'énergie utilisant directement ou indirectement un ou plusieurs dispositifs (3, 4, 7, 8) de travail et / ou de manipulation positionnés sur la machine d'exploitation forestière et commandés par un moyen (2) de commande. Lorsque le moyen de commande de la machine d'exploitation forestière communique à un ou plusieurs dispositifs de travail et / ou de manipulation une commande de contrôle amorçant une opération de changement, celle-ci est transmise sensiblement simultanément à la source d'énergie. A l'arrivée à la source d'énergie, une ou plusieurs commandes de contrôle nécessitant une variation de puissance de la source d'énergie affectent des paramètres de contrôle de la source d'énergie par une prédiction de la charge future de la source d'énergie.
Patent EP-1985721-A4 (EP)
Title: High-strength spring steel excellent in brittle fracture resistance and method for producing same
Inventor: KOCHI TAKUYA
IPC: C22C38/34
Filed: 2007-01-23
Abstract: A spring steel having a high strength of 1900 MPa or more and superior in the brittle fracture resistance, as well as a method for manufacturing the same, are provided. The high strength spring steel comprises, as basic components in mass %, C: 0.4-0.6%, Si: 1.4-3.0%, Mn: 0.1-1.0%, Cr: 0.2-2.5%, P: 0.025% or less, S: 0.025% or less, N: 0.006% or less, Al: 0.1% or less, and O: 0.003% or less, the amount of solute C being 0.15% or less, the amount of Cr contained as a Cr-containing precipitate being 0.10% or less, and a TS value represented by the following equation being 24.8% or more, and in point of structure, the pre-austenite grain diameter being 10 µm or smaller, wherein TS = 28.5*[C]+4.9*[Si]+0.5*[Mn]+2.5*[Cr]+1.7*[V]+3.7*[Mo] where [X] stands for mass % of element X.
Patent EP-2059205-A4 (EP)
Title: Processes for the production of solid dressing for treating wounded tissue
Inventor: MACPHEE MARTIN
IPC: A61F13/00
Filed: 2007-08-06
Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of fibrinogen and a fibrinogen activator, wherein the fibrinogen is present in an amount between 3.0 mg/cm2 of the wound facing surface of the dressing and 13.0 mg/cm2 of the wound facing surface of the dressing. Also disclosed are methods for treating wounded tissue.
Patent EP-2102713-A4 (EP)
Title: Charge adjuvants in electrostatic inks
Inventor: SILCOFF ELLIAD
IPC: G03G9/135
Filed: 2007-12-21
Abstract: Ink toners, electroink compositions, methods of making ink toners, methods of making electroink compositions, and the like, are described.
Patent EP-2200711-A4 (EP)
Title: Treadmill with automatic speed control, control module of the same and control method of the same
Inventor: PARK JAE-SANG
IPC: A63B24/00
Filed: 2008-01-31
Abstract: A treadmill includes a body having a belt for supporting an exerciser, an exerciser detecting portion installed in a predetermined area of the body to detect movement of the exerciser, a driving motor coupled to the body to drive the belt, a control portion for generating a first control signal for adjusting a rotation speed of the driving motor based on a signal received from the exerciser detecting portion, a motor driving portion for adjusting the rotation speed of the driving motor according to the first control signal received from the control portion, and an electrical braking portion for reducing the rotation speed of the driving motor. The treadmill quickly follows acceleration or deceleration of an exerciser; provides an experience as if the exerciser is exercising on the ground, thereby improve an exerciser's exercising experience; accepts various exercising patterns of an exerciser; resolves a problem in that a motor driving portion is tripped due to a load caused by quick deceleration; and preprocesses measured values of an exerciser's position to resolve a problem in that a speed of a belt cannot be controlled due to measurement errors contained in measured values.
Patent EP-2297708-A4 (EP)
Title: Buffered bookkeeping
Inventor: CHENG LI
IPC: G06Q40/02
Filed: 2009-07-02
Abstract: A method and a system use buffered bookkeeping to update an account timely for a user to see the account information without having to wait until the next accounting date. The method records request events to generate a buffer record of the request events for an account having high-volume concurrent transactions, and fetches and processes the buffer record periodically at predetermined time intervals or recursively for bookkeeping of the request events in the account without waiting for the next accounting date. The transaction funds in the account are made available for inquiries and become accessible after only a short period of time upon the occurrence of the transaction. The length of the delay is configurable according to the level of concurrent transactions of the account.
Patent EP-2526686-A4 (EP)
Title: A method, device and system for determining the presence of volatile organic compounds (voc) in video
Inventor: CETIN AHMET ENIS
IPC: H04N5/33
Filed: 2011-01-19
Abstract: A video based method to detect volatile organic compounds (VOC) leaking out of components used in chemical processes in petrochemical refineries. Leaking VOC plume from a damaged component has distinctive properties that can be detected in realtime by an analysis of images from a combination of infrared and optical cameras. Particular VOC vapors have unique absorption bands, which allow these vapors to be detected and distinguished. A method of comparative analysis of images from a suitable combination of cameras, each covering a range in the IR or visible spectrum, is described. VOC vapors also cause the edges present in image frames to loose their sharpness, leading to a decrease in the high frequency content of the image. Analysis of image sequence frequency data from visible and infrared cameras enable detection of VOC plumes. Analysis techniques using adaptive background subtraction, sub-band analysis, threshold adaptation, and Markov modeling are described.
Patent EP-2536430-A4 (EP)
Title: Compositions and methods for targeting type 1 interferon producing cells
Inventor: VAIRO GINO LUIGI
IPC: C07K16/28
Filed: 2011-02-17
Abstract: The present disclosure provides a method for treating lupus, Sjörgen's syndrome or scleroderma, the method comprising administering to the mammal an immunoglobulin which binds an interleukin 3 receptor a (IL-3Ra) chain and which depletes or at least partly eliminates plasmacytoid dendritic cells (p DCs) and basophils to which it binds.
Patent EP-2557927-A4 (EP)
Title: Fungicidal mixtures i comprising quinazolines
Inventor: MUELLER BERND
IPC: A01N63/38
Filed: 2011-04-12
Abstract: The present invention relates to fungicidal mixtures, comprising at least one quinazo-line compound I and one compound II as defined in the description, and to compositions comprising these mixtures.
Patent EP-2610373-A4 (EP)
Title: Fluorite
Inventor: YAMAZAKI TAKAFUMI
IPC: G02B1/02
Filed: 2011-06-30
Abstract: A fluorite having all the more excellent laser durability compared to a conventional fluorite is provided. A fluorite is proposed, in which the standard deviation of the surface areas of the Voronoi regions in a diagram from a Voronoi decomposition of the distribution of etch-pits in the (111) plane is 6,000 µm 2  or less, or, in which the standard deviation of the distances of the Delaunay edges in a diagram from a Delaunay decomposition of the distribution of etch-pits of the (111) plane is 80 µm or less.
Patent EP-0020375-A4 (EP)
Title: Heat exchanger having inclined tubes.
Inventor: HESTON DONALD W
IPC: F28D1/04
Filed: 1980-06-04
Abstract: A heat exchanger (10) has first and second cores (12, 14) arranged in a "V" configuration with the inner, directly adjacent ends being spaced apart a preselected distance for purging debris. The first core (12) has an axis "A" and a plurality of fins (40) defining an inlet surface (18) and an outlet end (44). An elongated tube (46) extends through the fins (40) and has a transverse axis "T" oriented with respect to axis "A" at a preselected angle to increase air flow and reduce pressure drop across the core. The second core (14) has a plurality of fins (40) defining an inlet surface (22) and an outlet end (44). The first and second core fins (40) are truncated at the corner defined by the respective inlet surface (18, 22) and outlet end (44) to expose more core surface area for a given frontal area.
Patent EP-0157833-A4 (EP)
Inventor: LEVEEN HARRY H
IPC: A61M25/10
Filed: 1984-09-19
Abstract: Catheter possédant une première et une deuxième structures de ballons gonflables (30A, 30B) avec un couplage à soupape (32) permettant aux structures de ballons (30A, 30B) de se séparer tout en restant gonflées. Le dispositif est particulièrement utile dans le traitement des anévrysmes. Le couplage à soupape (32) contient des composants de soupape séparés (50, 60) pouvant être aisément reliés ou séparés pendant une intervention chirurgicale.
Patent EP-0172257-A4 (EP)
Inventor: NAKASHIMA SEIICHIRO
IPC: B23K9/02
Filed: 1985-02-20
Abstract: Procédé de graduation pour une machine à souder automatique comportant un régulateur de robot pour réguler un robot tenant une torche à souder et où le régulateur de robot trouve des positions ultérieures qui sont enseignées sur la base des données d'instruction pour les positions des points de soudage primaires (P1, ..., Pn) de l'élément de soudage. La direction du vecteur normal $(1,4)$ sur la surface de l'élément de soudage (WK) est trouvée par un calcul reposant sur la donnée de trois points donnés (Q1, Q2, Q3) sur la surface de l'élément de soudage (WK). Sur la base de la direction dudit vecteur normal $(1,4)$, les points de graduation sont corrigés par rapport auxdits points de soudage primaire.
Patent EP-0289572-A4 (EP)
Title: Anti-arthritic use of interleukin-1 proteins.
Inventor: JACOBS CINDY A
IPC: C07K14/545
Filed: 1987-10-28
Abstract: Processes for use of interleukin-1 as an anti-arthritic agent are disclosed, comprising administration of an effective quantity of interleukin-1 (IL-1) in association with a pharmaceutical carrier, to an animal, including man.
Patent EP-0345301-A4 (EP)
Title: Ophthalmologic phantom system
IPC: G09B23/30
Filed: 1988-02-12
Abstract: A simulated human ocular system for practicing the surgical techniques required for the removal of cataractous lenses utilizing posterior chamber lens emulsification and, optionally, the techniques required for small incision implantation and refractive surgery. A human eye is generally imitated by an outer orb (5) having three inner, connected chambers separated by membranes that correspond to the cornea (23), the iris (29), and the posterior chamber, membrane (17). The lens phantom (21) consists of a structured, water-sensitive composition, such as a cross-linked gelatin to which a water soluble polymer has been added, and is thereafter encapsulated within a transparent vinyl or vinylidene chloride copolymer film. Placement of the ocular system in a structure (57) that duplicates the outside features of a human head, with provisions for varying the rotation and degree of ocular projection, completes this ocular model.
Patent EP-0370062-A4 (EP)
IPC: A23L27/24
Filed: 1988-07-28
Abstract: Une composition d'arôme de vanille est produite par des cellules de callus de vanillier en suspension dans une culture de tissus, dans des conditions qui favorisent la sécrétion de composants d'arôme de vanille dans le milieu de culture. Les composants d'arôme peuvent être séparés du milieu par des résines d'adsorption. Sont également décrits des procédés de préparation de cellules de callus pouvant sécréter des composants d'arôme dans une culture de tissus, ainsi que des cellules de callus produites par ces procédés.
Patent EP-0531529-A4 (EP)
Title: Process for preparing aqueous suspension
IPC: A61K9/00
Filed: 1991-07-11
Abstract: A process for preparing a stable aqueous suspension containing microcrystals of 5-(3-ethoxy-4-n-pentyloxyphenyl)thiazolidine-2,4-dione suitable as eye drops for treating praticularly corneal deseases, which comprises adding an acid to an aqueous solution of 5-(3-ethoxy-4-n-pentyloxyphenyl)thiazolidine-2,4-dione and at least one member selected from among polyvinyl alcohol, polyvinylpyrrolidone, hydroxypropylmethylcellulose, methylcellulose and hydroxyethylcellulose, said solution having a pH of at least 8, to lower the pH below 7.
Patent EP-0489152-A4 (EP)
Title: Thermoplastic compositions containing anhydrous zinc borate and a fluorocarbon polymer
IPC: C08L71/10
Filed: 1991-06-07
Abstract: Thermoplastic compositions comprising at least one polyetherimide and, as heat release retardants, anhydrous zinc borate and a non-fibrillating fluorocarbon polymer are disclosed. The compositions exhibit improved heat release characteristics.
Patent EP-0544814-A4 (EP)
IPC: B01L3/02
Filed: 1991-08-22
Abstract: A pipette (10) has a first and second piston (13, 14) to provide for a precise dose measurement and delivery and a second dose which can be an air blowout to fully expel the precise measured first dose. Preferably, two pistons are used of different diameter with a difference in diameters permitting precise measurement of small doses of, for example, 10 microleters or less.
Patent EP-0573605-A4 (EP)
Title: Preparation of factor ix.
Inventor: HUANG CHIN C
IPC: C07K16/00
Filed: 1992-02-26
Abstract: A novel method of protecting blood coagulation factor IX from proteases during purification or storage is disclosed. High concentrations of one or more water soluble organic or inorganic salts are used to stabilize factor IX, contained within blood plasma-derived solutions, or contained within solutions derived from other sources, against conversion to clinically unacceptable peptide structures such as factor IXa, and/or degraded factor IX peptides. The technique is useful in stabilizing intermediate purity factor IX preparations during purification, and in maintaining the integrity of purified factor IX during long term storage. Stable high specific activity factor IX preparations are also disclosed.